Home » Newsletters » BioWorld Science

BioWorld Science

July 12, 2000

View Archived Issues

Company Profile: ProlX Pharmaceuticals

Millennium to acquire Cambridge Discovery Chemistry

Pharmacokinetics and pharmacodynamics of selective ETA antagonist examined in humans

Schering-Plough enters asthma collaboration with Texas Biotechnology

Methods of differentiating response to INN-00835 and placebo described at CINP congress

Propranolol may improve disruptive agitation in AD without serious cardiovascular effects

Cymserine and analogues, potent and selective BChE inhibitors with potential in AD

Neotrofin as a novel approach to AD discussed at World Alzheimer Congress

Virax and IDT receive funding from U.S. NIH to develop HIV vaccines

NIH accelerates development of HIV vaccines

[18F]-L-829165: a promising PET tracer for the brain NK1 receptor

AlphaOne enters agreement with Dana-Farber for tumor suppressor gene

Biological characteristics of A-176120, a potent FPP mimetic with promise as a cancer therapeutic

Antisense collaboration established by Lorus Therapeutics and AVI BioPharma

PathoGenesis commences phase I trial of AeroDose TOBI

Murine and humanized monoclonal antibodies against alphav integrin receptors

Synthesis, activity and use of new gabapentin-related compounds

Novo Nordisk presents new heterocyclic inhibitors of factor VIIa-TF activity

New Yissum compounds useful against oxidative stress or free radical injury

Tetracycline derivatives with broad indications reported by CollaGenex

Novel cathepsin K inhibitors and their use in bone disorders patented

Broad-spectrum antibacterial compounds emerge from Daiichi R&D

UT researchers patent dibenzofluorene derivatives with cytotoxic activity

New series under development at Glaxo Wellcome inhibits hepatic ApoB-100 production

T-20 phase II results highlighted at AIDS Conference

Genta begins follow-up studies of Genasense combination therapy for prostate cancer

CV Therapeutics and Fujisawa form CVT-3146 collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...